NO20013257L - Beinstimulerende faktor - Google Patents
Beinstimulerende faktorInfo
- Publication number
- NO20013257L NO20013257L NO20013257A NO20013257A NO20013257L NO 20013257 L NO20013257 L NO 20013257L NO 20013257 A NO20013257 A NO 20013257A NO 20013257 A NO20013257 A NO 20013257A NO 20013257 L NO20013257 L NO 20013257L
- Authority
- NO
- Norway
- Prior art keywords
- stimulating factor
- ser gly
- subsequences
- pro lys
- bone stimulating
- Prior art date
Links
- 210000000988 bone and bone Anatomy 0.000 title 1
- 230000004936 stimulating effect Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- DENRBIYENOKSEX-PEXQALLHSA-N Gly-Ile-His Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 DENRBIYENOKSEX-PEXQALLHSA-N 0.000 abstract 1
- LNJLOZYNZFGJMM-DEQVHRJGSA-N Ile-His-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@@H]2C(=O)O)N LNJLOZYNZFGJMM-DEQVHRJGSA-N 0.000 abstract 1
- CKRFDMPBSWYOBT-PPCPHDFISA-N Ile-Lys-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N CKRFDMPBSWYOBT-PPCPHDFISA-N 0.000 abstract 1
- DEFGUIIUYAUEDU-ZPFDUUQYSA-N Lys-Asn-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O DEFGUIIUYAUEDU-ZPFDUUQYSA-N 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- SGAOHNPSEPVAFP-ZDLURKLDSA-N Thr-Ser-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SGAOHNPSEPVAFP-ZDLURKLDSA-N 0.000 abstract 1
- ZMYCLHFLHRVOEA-HEIBUPTGSA-N Thr-Thr-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ZMYCLHFLHRVOEA-HEIBUPTGSA-N 0.000 abstract 1
- 230000008468 bone growth Effects 0.000 abstract 1
- 230000012010 growth Effects 0.000 abstract 1
- 108010085325 histidylproline Proteins 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/229,304 US6693081B2 (en) | 1995-09-26 | 1999-01-13 | Bone stimulating factor |
| PCT/CA2000/000031 WO2000042069A1 (en) | 1999-01-13 | 2000-01-13 | Bone stimulating factor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20013257D0 NO20013257D0 (no) | 2001-06-29 |
| NO20013257L true NO20013257L (no) | 2001-08-17 |
Family
ID=22860649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20013257A NO20013257L (no) | 1999-01-13 | 2001-06-29 | Beinstimulerende faktor |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US6693081B2 (enExample) |
| EP (1) | EP1161450A1 (enExample) |
| JP (1) | JP2002538775A (enExample) |
| KR (1) | KR20010101425A (enExample) |
| CN (1) | CN1341120A (enExample) |
| AU (1) | AU779261B2 (enExample) |
| BG (1) | BG105682A (enExample) |
| BR (1) | BR0007816A (enExample) |
| CA (1) | CA2358908A1 (enExample) |
| CZ (1) | CZ20012456A3 (enExample) |
| HU (1) | HUP0105004A2 (enExample) |
| IL (1) | IL143990A0 (enExample) |
| IS (1) | IS5999A (enExample) |
| MA (1) | MA25594A1 (enExample) |
| MX (1) | MXPA01007043A (enExample) |
| NO (1) | NO20013257L (enExample) |
| NZ (1) | NZ512637A (enExample) |
| PL (1) | PL349786A1 (enExample) |
| WO (1) | WO2000042069A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6693081B2 (en) * | 1995-09-26 | 2004-02-17 | Osteopharm Inc. | Bone stimulating factor |
| AU5379200A (en) * | 1999-06-02 | 2000-12-28 | Osteopharm Inc. | Bone stimulating factor |
| WO2004015378A1 (en) * | 2002-07-05 | 2004-02-19 | Gaspardo Seminatrici S.P.A. | A volumetric metering device for the metered delivery of granular and powdery materials, particularly for machines for distributing the said materials |
| AU2003272814A1 (en) | 2003-10-02 | 2005-05-19 | Ibrahim Al-Habdan | Peptide for promoting healing of fractures |
| EP2718728A1 (en) * | 2011-06-10 | 2014-04-16 | Université Libre de Bruxelles | Targets and agents for the treatment of impaired bone fracture healing |
| CN103159762B (zh) * | 2013-03-25 | 2015-04-15 | 华东理工大学 | 表吲哚二酮衍生物及其用途 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4320118A (en) | 1980-12-22 | 1982-03-16 | Syntex (U.S.A.) Inc. | Deca-, undeca-, dodeca- and tridecapeptides with thymic activity |
| US4897348A (en) | 1983-08-25 | 1990-01-30 | Sri International | Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof |
| US4877864A (en) | 1987-03-26 | 1989-10-31 | Genetics Institute, Inc. | Osteoinductive factors |
| US5354557A (en) | 1988-04-08 | 1994-10-11 | Stryker Corporation | Osteogenic devices |
| US5011691A (en) | 1988-08-15 | 1991-04-30 | Stryker Corporation | Osteogenic devices |
| US5024841A (en) | 1988-06-30 | 1991-06-18 | Collagen Corporation | Collagen wound healing matrices and process for their production |
| US4950483A (en) | 1988-06-30 | 1990-08-21 | Collagen Corporation | Collagen wound healing matrices and process for their production |
| US5510418A (en) | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
| US5264214A (en) | 1988-11-21 | 1993-11-23 | Collagen Corporation | Composition for bone repair |
| JP3051160B2 (ja) * | 1988-12-08 | 2000-06-12 | ノバルティス・アクチエンゲゼルシャフト | 好中球活性化ペプチド‐２ |
| US5461034A (en) | 1989-02-23 | 1995-10-24 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Osteogenic growth polypeptides identified from regenerating bone marrow |
| EP0513201A1 (en) | 1990-02-01 | 1992-11-19 | University Of South Florida | Leukocyte-derived growth factor |
| CA2040264A1 (en) | 1990-04-12 | 1991-10-13 | Tatsuhiko Kanmera | Parathyroid hormone antagonists |
| AU668347B2 (en) | 1990-11-21 | 1996-05-02 | Torrey Pines Institute For Molecular Studies | Synthesis of equimolar multiple oligomer mixtures, especially of oligopeptide mixtures |
| US5776892A (en) * | 1990-12-21 | 1998-07-07 | Curative Health Services, Inc. | Anti-inflammatory peptides |
| CA2098921C (en) * | 1990-12-21 | 2000-12-05 | Russel B. Whitman | Angiogenic peptides |
| US5208219A (en) | 1991-02-14 | 1993-05-04 | Celtrix Pharmaceuticals Inc. | Method for inducing bone growth |
| EP0499242B1 (en) | 1991-02-15 | 1996-06-26 | Takeda Chemical Industries, Ltd. | Stimulation of endosteal bone formation with a cell growth factor |
| EP0504938A3 (en) | 1991-03-22 | 1993-04-14 | Suntory Limited | Prophylactic and therapeutic agent for bone diseases comprising di- or tripeptide derivative as active ingredient |
| US5643549A (en) * | 1992-02-20 | 1997-07-01 | Rhomed Incorporated | Leukostimulatory agent for in vivo leukocyte tagging |
| US5792664A (en) | 1992-05-29 | 1998-08-11 | The Rockefeller University | Methods for producing and analyzing biopolymer ladders |
| DE69332377T2 (de) * | 1992-07-13 | 2003-07-03 | Bionebraska, Inc. | Verfahren zur modifizierung rekombinanter polypeptide |
| US5304542A (en) | 1992-08-28 | 1994-04-19 | University Of Louisville Research Foundation, Inc. | Use of platelet factor 4 to inhibit osteoblast proliferation |
| US5578569A (en) | 1993-03-12 | 1996-11-26 | Tam; Cherk S. | Method of increasing bone growth |
| US5786327A (en) | 1993-03-12 | 1998-07-28 | Gensci Regeneration Sciences Inc. | Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same |
| IL108947A0 (en) * | 1993-03-12 | 1994-06-24 | Osteopharm Ltd | Bone stimulating factor |
| US5661127A (en) | 1995-05-01 | 1997-08-26 | The Regents Of The University Of California | Peptide compositions with growth factor-like activity |
| US6352973B1 (en) | 1995-06-07 | 2002-03-05 | Osteopharm Inc. | Bone stimulating factor |
| US5880094A (en) | 1995-06-07 | 1999-03-09 | Osteopharm Limited | Polypeptides that stimulate bone growth |
| US6117839A (en) | 1995-06-07 | 2000-09-12 | Gensci Regeneration Sciences, Inc. | Bone stimulating factor |
| ZA968062B (en) | 1995-09-26 | 1997-06-18 | Osteopharm Ltd | Bone stimulating factor |
| US6693081B2 (en) * | 1995-09-26 | 2004-02-17 | Osteopharm Inc. | Bone stimulating factor |
-
1999
- 1999-01-13 US US09/229,304 patent/US6693081B2/en not_active Expired - Fee Related
-
2000
- 2000-01-13 EP EP00900467A patent/EP1161450A1/en not_active Withdrawn
- 2000-01-13 MX MXPA01007043A patent/MXPA01007043A/es not_active Application Discontinuation
- 2000-01-13 KR KR1020017008634A patent/KR20010101425A/ko not_active Withdrawn
- 2000-01-13 JP JP2000593635A patent/JP2002538775A/ja active Pending
- 2000-01-13 WO PCT/CA2000/000031 patent/WO2000042069A1/en not_active Ceased
- 2000-01-13 BR BR0007816-6A patent/BR0007816A/pt not_active Application Discontinuation
- 2000-01-13 CA CA002358908A patent/CA2358908A1/en not_active Abandoned
- 2000-01-13 CN CN00802780A patent/CN1341120A/zh active Pending
- 2000-01-13 PL PL00349786A patent/PL349786A1/xx not_active Application Discontinuation
- 2000-01-13 NZ NZ512637A patent/NZ512637A/en unknown
- 2000-01-13 AU AU30282/00A patent/AU779261B2/en not_active Ceased
- 2000-01-13 HU HU0105004A patent/HUP0105004A2/hu unknown
- 2000-01-13 IL IL143990A patent/IL143990A0/xx unknown
- 2000-01-13 CZ CZ20012456A patent/CZ20012456A3/cs unknown
-
2001
- 2001-06-29 NO NO20013257A patent/NO20013257L/no not_active Application Discontinuation
- 2001-07-09 BG BG105682A patent/BG105682A/xx unknown
- 2001-07-09 MA MA26261A patent/MA25594A1/fr unknown
- 2001-07-11 IS IS5999A patent/IS5999A/is unknown
-
2003
- 2003-11-24 US US10/718,526 patent/US20040147450A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20020090671A1 (en) | 2002-07-11 |
| KR20010101425A (ko) | 2001-11-14 |
| CN1341120A (zh) | 2002-03-20 |
| CZ20012456A3 (cs) | 2002-02-13 |
| BG105682A (en) | 2003-04-30 |
| MA25594A1 (fr) | 2002-12-31 |
| NO20013257D0 (no) | 2001-06-29 |
| WO2000042069A1 (en) | 2000-07-20 |
| IS5999A (is) | 2001-07-11 |
| AU3028200A (en) | 2000-08-01 |
| MXPA01007043A (es) | 2002-03-27 |
| US6693081B2 (en) | 2004-02-17 |
| EP1161450A1 (en) | 2001-12-12 |
| BR0007816A (pt) | 2002-12-31 |
| US20040147450A1 (en) | 2004-07-29 |
| NZ512637A (en) | 2003-08-29 |
| PL349786A1 (en) | 2002-09-09 |
| CA2358908A1 (en) | 2000-07-20 |
| AU779261B2 (en) | 2005-01-13 |
| IL143990A0 (en) | 2002-04-21 |
| JP2002538775A (ja) | 2002-11-19 |
| HUP0105004A2 (hu) | 2002-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300013I2 (nl) | Nieuwe proteinen me TNF-remmende werking en hun bereiding. | |
| DE69638162D1 (de) | Bindegewebs wachstumsfaktor (ctgf) | |
| EP0751992A4 (en) | VASCULAR ENDOTHELIAL GROWTH FACTOR 2 | |
| DK0643726T3 (da) | Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei | |
| DE69435075D1 (de) | , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten | |
| HUP0200418A2 (hu) | Új citokin zalpha 11 ligandum | |
| DE68929043D1 (de) | Für androgen-rezeptor-protein kodierende dna | |
| EP1012173B1 (en) | Isolated decapeptides which bind to hla molecules, and the use thereof | |
| NO20014417L (no) | Vaskul¶re adhesjonsmolekyler samt modulering av deres funksjon | |
| ATE63126T1 (de) | Tetra- und penta-peptide mit der sequenz lysylarginyl-aspartyl, und ihre verwendung als antithrombotika. | |
| DE60143818D1 (de) | Alpha-fetoprotein-peptide und ihre verwendung | |
| RU98112759A (ru) | Человеческий семафорин l (h-sema-l) и соответствующие семафорины в других видах | |
| NO20011460L (no) | Cytokinreseptor zalphall | |
| NO952385D0 (no) | Fremgangsmåte til identifisering av individer med unormale celler som uttrykker HLA-A2/tyrosinasepeptidantigen | |
| NO975565L (no) | Benstimulerende faktor | |
| BG105682A (en) | Bone stimulating factor | |
| ATE177843T1 (de) | Peptomere mit erhöhter immunogenizität | |
| WO1997012036A3 (en) | Bone stimulating factor | |
| DE60031414D1 (de) | Einkettige polypeptide enthaltend n-terminale troponin i fragmente und troponin c | |
| NO942360L (no) | Vaksine og polypeptider som er nyttige for denne | |
| AU1444699A (en) | Single-chain polypeptides comprising troponin i and troponin | |
| HUP9702500A2 (hu) | Elhízás elleni proteinek | |
| DK0616642T3 (da) | Hidtil ukendte thrombininhibitoriske proteiner fra landblodigler | |
| WO1998054209A3 (en) | Human mast cell function-associated antigen (mafa) and uses thereof | |
| DE69534324D1 (de) | Menschliche scf, eine spleissvariante davon,ihre pharmazeutische verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |